Micro-RNAs involved in macular degeneration
US9598694B2 · kind B2 · utility
0Cited by
2References
22Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 2, 2013 |
| Grant date | Mar 21, 2017 |
| Priority date | — |
| Expiry date | May 2, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/3231
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the involvement of miR function in the development of age-related macular degeneration (AMD). It is shown that miR-23, miR-24 and/or miR-27 are involved in pathologic neovascularization in AMD, and that agonism (miR-24) and inhibition (miR23/27) of the function of these molecules blocks events contributing to development and progression of disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.